Corrigendum to "Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group" [Radiother Oncol 81 (2006) 9-17] (DOI:10.1016/j.radonc.2006.09.001);Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group

Radiotherapy and Oncology

Volumn 81, Issue 1, 2006, Pages 9-17

  Gogna, Nirdosh Kumar ^a   Matthews, John H L ^b   Turner, Sandra L ^c   Mameghan, Heidi ^d   Duchesne, Gillian M ^d   Spry, Nigel ^e   Berry, Martin P ^f   Keller, Jacqui ^g   Tripcony, Lee ^g  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c WESTMEAD HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^f LIVERPOOL HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Bladder transitional cell carcinoma; Chemoradiation; Weekly cisplatin

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD TOXICITY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONCOLOGY; PELVIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SEPSIS; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; URINARY TRACT INFECTION;

EID: 33749446054     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.03.005     Document Type: Erratum

References (21)

1. Bochner B.H., Figueroa A.J., Skinner E.C., et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 160 (1998) 29-33
2. Coppin C.M., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 14 (1996) 2901-2907
3. Eapen L., Stewart D., Danjoux C., et al. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J Clin Oncol 7 (1989) 230-235
4. Gospodarowicz M.K., and Warde P. The role of radiation therapy in the management of transitional cell carcinoma of the bladder. Hematol Oncol Clin North Am 6 1 (1992) 147-168
5. Housset M., Maulard C., Chretien Y., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11 (1993) 2150-2157
6. Jenkins B.J., Caulfield M.J., Fowler C.G., et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62 (1988) 343-346
7. Kallman R.F., Bedarida G., and Rapacchietta D. Experimental studies on schedule dependence in the treatment of cancer with combinations of chemotherapy and radiotherapy. In: Meyer J.L., and Vaeth J.M. (Eds). Radiotherapy/Chemotherapy interactions in cancer therapy Vol. 25 (1992), Front Radiat Ther Oncol, Karger, Basel 31-44
8. Konnak J.W., and Grossman H.B. Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder. Urology 26 (1985) 550-553
9. Maciejewski B., and Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 21 (1991) 163-170
10. Marks L.B., Kaufman S.D., Prout Jr. G.R., et al. Invasive bladder carcinoma: preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (methotrexate, cisplatin, and vinblastine) chemotherapy and pelvic irradiation plus cisplatin. Int J Radiat Oncol Biol Phys 15 (1988) 877-883
11. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 1999;354:533-40.
12. Rodel C., Weiss C., and Sauer R. Organ preservation by combined modality treatment in bladder cancer: the European perspective. Semin Radiat Oncol 15 (2005) 28-35
13. Rose P.G. Chemoradiotherapy for cervical cancer. Eur J Cancer 38 (2002) 270-278
14. Sauer R., Birkenhake S., Kuhn R., et al. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 40 (1998) 121-127
15. Sauer R., Dunst J., Altendorf-Hofmann A., et al. Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 19 (1990) 687-691
16. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
17. Shipley W.U., Prout Jr. G.R., Kaufman S.D., et al. Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60 (1987) 514-520
18. Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
19. Tester W., Porter A., Asbell S., et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 25 (1993) 783-790
20. Zietman A.L., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58 (2001) 380-385
21. Zietman A.L., Sacco D., Skowronski U., et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170 (2003) 1772-1776